HSBC Cuts Zoetis Inc. (ZTS)’s Price Target To $140 From $180, Keeps Buy Rating

Yahoo Finance Published Updated Stocks
Sign in to save

Affected assets and topics

S&P INVESTMENT NYSE SHARES

Why it matters

HSBC lowered the price target for Zoetis Inc. (ZTS) to $140 from $180, while maintaining a Buy rating, indicating a decrease in expected stock value but still a positive outlook.

Article tone

Neutral How the article is written, as reported by the source.

Expected market reaction

Bearish Confidence 71% How confidence is read Impact: Moderate

Market impact analysis based on bearish sentiment with 71% confidence.

Evidence trail

Evidence
Source Yahoo Finance
Claim HSBC Cuts Zoetis Inc. (ZTS)’s Price Target To $140 From $180, Keeps Buy Rating
AI inference Bearish · 71%
Generated 2025-12-13 03:58

AI provenance

Analysed by Llama 3.1 8B Instant (Groq) Methodology v1.0 Generated
Technical identifiers
Provider tag
groq-llama-3.1-8b-instant
Analysis version
groq-llama-3.1-8b-instant
Article id
22025

Original source

Zoetis Inc. (NYSE:ZTS) is among the 11 Most Oversold S&P 500 Stocks Heading into 2026. On December 10, HSBC slashed its price target on the stock to $140 from $180, as part of the firm’s broader overview of pharmaceutical stocks for 2026. However, the investment bank maintained its earlier Buy rating for the shares. It […]

Read the full article on Yahoo Finance

Original article published by Yahoo Finance on December 13, 2025. Analysis and insights provided by AnalystMarkets AI.

Related coverage